Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Suitability and efficacy of submucosal tunneling endoscopic resection for the treatment of giant leiomyoma in the middle and lower esophagus.

Du Z, Ding W, Chen T.

Dis Esophagus. 2019 Jun 17. pii: doz059. doi: 10.1093/dote/doz059. [Epub ahead of print]

PMID:
31206575
2.

A Novel Regulator of Preadipocyte Differentiation, Transcription Factor TCF21, Functions Partially Through Promoting LPL Expression.

Zhang X, Cheng B, Liu C, Du Z, Zhang H, Wang N, Wu M, Li Y, Cao Z, Li H.

Front Physiol. 2019 Apr 23;10:458. doi: 10.3389/fphys.2019.00458. eCollection 2019.

3.

Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study.

Cai Q, Zhu C, Yuan Y, Feng Q, Feng Y, Hao Y, Li J, Zhang K, Ye G, Ye L, Lv N, Zhang S, Liu C, Li M, Liu Q, Li R, Pan J, Yang X, Zhu X, Li Y, Lao B, Ling A, Chen H, Li X, Xu P, Zhou J, Liu B, Du Z, Du Y, Li Z; Gastrointestinal Early Cancer Prevention & Treatment Alliance of China (GECA).

Gut. 2019 Sep;68(9):1576-1587. doi: 10.1136/gutjnl-2018-317556. Epub 2019 Mar 29.

4.

Acute-Phase Plasma PCSK9 Levels and Recurrent Cardiovascular Events in a Chinese Acute Myocardial Infarction Cohort.

Gao Y, Qiu Y, Wu J, Diao W, Zhang H, Wang S, Du Z, Dong J, Zhang M, Jiang L.

Cardiology. 2018;141(2):88-97. doi: 10.1159/000493785. Epub 2018 Nov 13.

PMID:
30423567
5.

A brief overview of the Swi1 prion-[SWI+].

Goncharoff DK, Du Z, Li L.

FEMS Yeast Res. 2018 Sep 1;18(6). doi: 10.1093/femsyr/foy061. Review.

6.

Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia.

Deng M, Zha J, Jiang Z, Jia X, Shi Y, Li P, Chen XL, Fang Z, Du Z, Xu B.

J Transl Med. 2018 Feb 28;16(1):47. doi: 10.1186/s12967-018-1421-y.

7.

Analysis of Small Critical Regions of Swi1 Conferring Prion Formation, Maintenance, and Transmission.

Valtierra S, Du Z, Li L.

Mol Cell Biol. 2017 Sep 26;37(20). pii: e00206-17. doi: 10.1128/MCB.00206-17. Print 2017 Oct 15.

8.

Analysis of [SWI+ ] formation and propagation events.

Du Z, Goncharoff DK, Cheng X, Li L.

Mol Microbiol. 2017 Apr;104(1):105-124. doi: 10.1111/mmi.13616. Epub 2017 Jan 26.

9.

SUCCESSFUL CONSERVATIVE TREATMENT OF AN ELDERLY PATIENT WITH AN ERCP-RELATED DUODENAL PERFORATION ASSOCIATED WITH WIDESPREAD SUBCUTANEOUS EMPHYSEMA.

Li X, Peng Q, Zhang Q, Liu Y, Du Z, Wang C.

Gastroenterol Nurs. 2018 May/Jun;41(3):240-243. doi: 10.1097/SGA.0000000000000260. Review. No abstract available.

10.
11.

Preclinical Evaluation of AMG 337, a Highly Selective Small Molecule MET Inhibitor, in Hepatocellular Carcinoma.

Du Z, Caenepeel S, Shen Y, Rex K, Zhang Y, He Y, Tang ET, Wang O, Zhong W, Zhou H, Huang J, Huang E, Hu L, Coxon A, Zhang M.

Mol Cancer Ther. 2016 Jun;15(6):1227-37. doi: 10.1158/1535-7163.MCT-15-0745. Epub 2016 Mar 29.

12.

Biomarker development in MET-targeted therapy.

Zhang Y, Du Z, Zhang M.

Oncotarget. 2016 Jun 14;7(24):37370-37389. doi: 10.18632/oncotarget.8276. Review.

13.

Detection of MET Gene Copy Number in Cancer Samples Using the Droplet Digital PCR Method.

Zhang Y, Tang ET, Du Z.

PLoS One. 2016 Jan 14;11(1):e0146784. doi: 10.1371/journal.pone.0146784. eCollection 2016.

14.

The Yeast Prion [SWI(+)] Abolishes Multicellular Growth by Triggering Conformational Changes of Multiple Regulators Required for Flocculin Gene Expression.

Du Z, Zhang Y, Li L.

Cell Rep. 2015 Dec 29;13(12):2865-78. doi: 10.1016/j.celrep.2015.11.060. Epub 2015 Dec 17.

15.

An insight into the complex prion-prion interaction network in the budding yeast Saccharomyces cerevisiae.

Du Z, Valtierra S, Li L.

Prion. 2014;8(6):387-92. doi: 10.4161/19336896.2014.992274.

16.

Investigating the interactions of yeast prions: [SWI+], [PSI+], and [PIN+].

Du Z, Li L.

Genetics. 2014 Jun;197(2):685-700. doi: 10.1534/genetics.114.163402. Epub 2014 Apr 11.

17.

Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy.

Mehran R, Nilsson M, Khajavi M, Du Z, Cascone T, Wu HK, Cortes A, Xu L, Zurita A, Schier R, Riedel B, El-Zein R, Heymach JV.

Cancer Res. 2014 May 15;74(10):2731-41. doi: 10.1158/0008-5472.CAN-13-2044. Epub 2014 Mar 13.

18.

The complexity and implications of yeast prion domains.

Du Z.

Prion. 2011 Oct-Dec;5(4):311-6. doi: 10.4161/pri.18304. Epub 2011 Oct 1. Review.

19.

A small, glutamine-free domain propagates the [SWI(+)] prion in budding yeast.

Crow ET, Du Z, Li L.

Mol Cell Biol. 2011 Aug;31(16):3436-44. doi: 10.1128/MCB.05338-11. Epub 2011 Jun 13.

20.

Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma.

Cascone T, Herynk MH, Xu L, Du Z, Kadara H, Nilsson MB, Oborn CJ, Park YY, Erez B, Jacoby JJ, Lee JS, Lin HY, Ciardiello F, Herbst RS, Langley RR, Heymach JV.

J Clin Invest. 2011 Apr;121(4):1313-28. doi: 10.1172/JCI42405. Epub 2011 Mar 23.

Supplemental Content

Loading ...
Support Center